|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| C07K 16/28 | (2006.01) |
| (11) | Number of the document | 2785375 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12790432.4 |
| Date of filing the European patent application | 2012-11-21 | |
| (97) | Date of publication of the European application | 2014-10-08 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-22 |
| (46) | Date of publication of the claims translation | 2020-11-10 |
| (86) | Number | PCT/EP2012/004822 |
| Date | 2012-11-21 |
| (87) | Number | WO 2013/079174 |
| Date | 2013-06-06 |
| (30) | Number | Date | Country code |
| 201161563903 P | 2011-11-28 | US |
| (72) |
NASTRI, Horacio, G., US
IFFLAND, Christel, US
LEGER, Olivier, FR
AN, Qi, US
CARTWRIGHT, Mark, US
McKENNA, Sean, D., US
SOOD, Vanita, D., US
HAO, Gang, US
|
| (73) |
Merck Patent GmbH,
Frankfurter Strasse 250, 64293 Darmstadt,
DE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Anti-PD-L1 antikūnai ir jų panaudojimas |
| ANTI-PD-L1 ANTIBODIES AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2025-10-22 | 14 | 289.00 EUR |
| 2026-11-21 |